维普期刊资源整合服务平台（V6.5）

60篇 您的检索式：作者名="Bachet J"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Thoracic en- dovascular aortic repair (TEVAR) for the treatment of aortic diseases显示文摘	Grabenwoger M Alfonso F Bachet J	2012	Eur Heart J2012，33，13：	1
2	KRAS mutations as an independent prognostic factor in pa- tients with advanced colorectal cancer treated with cetuximab 显示文摘	Lievre A Bachet J B Boige V Cayre A Le Corre D Buc E	2008	J Clin Oncol2008，26，：	1
3	Cerebral protection during aortic arch surgery显示文摘	Bachet J		0，，：	1
4	K-RAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab显示文摘	LIEVRE A BACHET J B BOIGE V	2008	J Clin 379 Oncol2008，26，3：	1
5	KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with eetuximab显示文摘	Lievre A Bachet J B Boige V	2008	J Clin Onco12008，26，3：	1
6	Antegrade Cerebral perfusi0n with cold blod:a 13 year experience显示文摘	Bachet J Guilmet D Goudot B		0，，：	1
7	Modern temperature management in aortic arch surgery: the dilemma of moderate hypothermia显示文摘	Luehr M Bachet J Mohr FW	2014	Eur J Cardiothorac Surg2014，45，1：	1
8	K-ras mutation status is predictive of response to Cctuximab therapy in colorectal cancer 显示文摘	LIEVRE A BACHET J B Le CORRE D	2006	Cancer Res2006，66，8：	1
9	Brain protection during surgery of the aortic arch显示文摘	Bachet J Guilmet D	2002	J Card Surg2002，17，2：	1
10	KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer显示文摘	Astrid L Bachet Bachet J	2006	Cancer Res2006，66，8：	1
11	Brain protection surgery of the aortic arch显示文摘	Bachet J Guilmet D	2002	J Card Surg2002，17，2：	1
12	Acute type A aortic dissection:can we dramatically reduce the surgical mortality?显示文摘	BACHET J	2002	Ann Thorac Surg2002，73，3：	1
13	The use of biological glue in aortic surgery显示文摘	Bachet J Guflmet D	1999	Cardiol Clin1999，17，4：	1
14	Asparagine synthetase expres- sion and phase I study with L - Asparaginase encapsulated in red blood cells in patients with pancreatic adenocarcinoma 显示文摘	Bachet J Gay F Mar6chal R	2015	Pancreas2015，44，7：	1
15	KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer 显示文摘	Lievre A Bachet J B Le Corre D	2006	CancerRes2006，66，8：	1
16	How do we protect the brain? Antegrade selective cerebral perfusion with cold blood during aortic arch surgery显示文摘	Bachet J Guodot B Dreyfus G	1997	J Cardia Surg1997，，：	1
17	KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab显示文摘	Lievre A Bachet J B Boige V	2008	J Clin Oncol2008，26，3：	1
18	Antegrade cerebral perfu- sion with cold blood: a 13-year experience显示文摘	Bachet J Guilmet D Goudot B	1999	Ann Thorac Surg1999，67，6：	1
19	How do we protect the brain ? Antegrade selective cerebral perfusion with cold blood during aortic arch surgery显示文摘	GROUDOT B DREYFUS G	1997	J Card Surg1997，，：	1
20	KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer显示文摘	Lievre A Bachet J Corre DL	2006	Cancer Res2006，66，8：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示